An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease
Clinical trial NCT03034538 · SUSPENDED
Trial details
- NCT number
- NCT03034538
- Sponsor
- The Cooper Health System
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-08
- Primary completion
- 2022-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.